🔗 Share this article

Chancellor Reeves has stated she is planning "specific action to address cost of living pressures" in next month's financial statement.

Speaking to the BBC, she emphasized that curbing inflation is a collective responsibility of both the administration and the Bank of England.

The United Kingdom's inflation rate is forecast to be the most elevated among the G7 advanced economies this calendar year and next.

Potential Utility Cost Measures

Sources suggest the government could intervene to lower energy bills, for example by reducing the present 5% level of value-added tax applied on energy.

A further option is to cut some of the policy costs presently added to household expenses.

Budgetary Limitations and Expert Expectations

The administration will receive the latest draft from the independent fiscal watchdog, the OBR, on the start of the week, which will reveal how much space there is for these measures.

The expectation from most analysts is that Reeves will have to declare higher taxes or spending cuts in order to meet her declared borrowing rules.

Previously on Thursday, calculations showed there was a twenty-two billion pound shortfall for the chancellor to address, which is at the more modest range of expectations.

"It is a joint responsibility between the central bank and the government to continue tackling some of the sources of price increases," the Chancellor told reporters in the US capital, at the yearly gatherings of the IMF and global financial institution.

Revenue Pledges and International Issues

While a great deal of the focus has been on probable tax rises, the chancellor said the latest information from the fiscal watchdog had not changed her pledge to election pledges not to increase rates on earnings tax, VAT or social security contributions.

She attributed an "unpredictable world" with growing geopolitical and trade tensions for the Budget revenue measures, likely to be focused on those "wealthiest."

Global Economic Tensions

Referring to apprehensions about the United Kingdom's economic relations with the Asian nation she said: "Our security interests always are paramount."

Last week's announcement by Chinese authorities to tighten trade restrictions on rare earths and other materials that are crucial for high-technology production led US President the US President to threaten an extra 100% tariff on goods from the Asian country, increasing the risk of an full-scale trade war between the two largest economies.

The US Treasury Secretary labeled China's decision "economic coercion" and "a global supply chain power grab."

Asked about considering the US offer to participate in its dispute with China, the Chancellor said she was "very concerned" by Chinese actions and urged the Chinese government "to avoid restrictions and limit trade."

She said the move was "bad for the world economy and generates additional obstacles."

"In my view there are sectors where we need to confront Chinese policies, but there are also important prospects to export to China's economy, including banking sector and other sectors of the economy. We've got to achieve that balance right."

The chancellor also stated she was collaborating with G7 counterparts "regarding our own essential resources plan, so that we are reduced dependence."

Health Service Medicine Pricing and Investment

The Chancellor also acknowledged that the cost the NHS spends on medicines could increase as a consequence of ongoing discussions with the US government and its pharmaceutical firms, in return for reduced taxes and funding.

A number of the world's largest drug companies have said in recent statements that they are either halting or canceling projects in the United Kingdom, with several attributing the low prices they are getting.

Recently, the Science Minister said the price the NHS pays for drugs would need to go up to prevent businesses and pharmaceutical investment departing from the UK.

Reeves told the BBC: "We have seen as a result of the pricing regime, that clinical trials, recent pharmaceuticals have not been available in the United Kingdom in the way that they are in other European countries."

"We want to make sure that individuals receiving care from the NHS are able to receive the top life-saving drugs in the globe. And so we are examining all of that, and... seeking to obtain increased capital into Britain."